STAI Y1 anxiety measurement of the change from post-test score to pre-test score.
The STAI Y1 has 20 questions on a scale from 1 to 4. The minimum score is 20 and the maximum is 80. The lower the score the better the outcome. Our outcome looks at the difference between the post-test from the pre-test, so the minimum change score is -60 and the maximum change score is 60. A higher change in score would mean that a subject experienced a worse outcome after the paradigm, while a lower change in score shows a better outcome after the paradigm than before.
Group
Value
95% CI
A = Virtual Reality Paradigm A
-6.4
± 5.98
B = Virtual Reality Paradigm B
-5.8
± 9.29
C = Non-Virtual Reality Paradigm A
-4.1
± 6.22
D = Non-Virtual Reality Paradigm B
-5.0
± 6.89
Was the Study WorthwhileSecondary· 2 weeks
Acceptability of Virtual Reality measured by a question from the satisfaction survey done at the end of the study. The question asked was "Was it worthwhile for you to participate in this research study?".
Group
Value
95% CI
A = Virtual Reality Paradigm A
0
B = Virtual Reality Paradigm B
0
C = Non-Virtual Reality Paradigm A
1
D = Non-Virtual Reality Paradigm B
0
A = Virtual Reality Paradigm A
6
B = Virtual Reality Paradigm B
6
C = Non-Virtual Reality Paradigm A
5
D = Non-Virtual Reality Paradigm B
5
A = Virtual Reality Paradigm A
0
B = Virtual Reality Paradigm B
0
C = Non-Virtual Reality Paradigm A
0
D = Non-Virtual Reality Paradigm B
1
Sponsor's own description
The purpose of this study is to evaluate the acceptability of using Virtual Reality intervention to help reduce anxiety and burnout symptoms and improve focus in the workplace.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or
· Phase 2
· recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety
· NA
· recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients
· NA
· recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years
· NA
· recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect
· recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
· NA
· not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
· not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance,
· NA
· not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
· NA
· recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 2 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04622527.